Not applicableStudy completedNCT00506597What this trial is testingErwinase Study in Patients With Acute Lymphoblastic LeukemiaWho this might be right forLeukemia M.D. Anderson Cancer Center 33
Very early researchEnded earlyNCT01878708What this trial is testingA Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell LymphomaWho this might be right forT-Cell LymphomaRelapsed T-Cell LymphomaRefractory T-Cell Lymphoma Dana-Farber Cancer Institute 2
Testing effectiveness (Phase 2)WithdrawnNCT02718755What this trial is testingPhase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic MalignanciesWho this might be right forHematologic Malignancy M.D. Anderson Cancer Center
Not applicableNo Longer AvailableNCT02197650What this trial is testingExpanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of AsparaginaseWho this might be right forAcute Lymphoblastic Leukemia ERYtech Pharma
Large-scale testing (Phase 3)UnknownNCT03623087What this trial is testingSIMPLE Chemotherapy for NK Lymphoma/LeukaemiaWho this might be right forNon-Hodgkin's Lymphoma, RelapsedNon-Hodgkin T-cell LymphomaNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type The University of Hong Kong 68
Testing effectiveness (Phase 2)Looking for participantsNCT04195347What this trial is testingStudy of CM4620 to Reduce the Severity of Pancreatitis Due to AsparaginaseWho this might be right forAcute Pancreatitis St. Jude Children's Research Hospital 42
Testing effectiveness (Phase 2)Study completedNCT02067143What this trial is testingMRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted MethotrexateWho this might be right forUntreated Philadelphia Positive Acute Lymphoblastic LeukemiaDe NovoSecondary+1 more Gruppo Italiano Malattie EMatologiche dell'Adulto 204
Testing effectiveness (Phase 2)Ended earlyNCT02419469What this trial is testingAugmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forLeukemiaPrecursor-B Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma+1 more M.D. Anderson Cancer Center 1
Large-scale testing (Phase 3)Study completedNCT01518517What this trial is testingGRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia, in Relapse ERYtech Pharma 85
Testing effectiveness (Phase 2)Ended earlyNCT01005914What this trial is testingPegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaWho this might be right forLeukemia OHSU Knight Cancer Institute 11
Testing effectiveness (Phase 2)Study completedNCT00283985What this trial is testingAssociation of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell LymphomaWho this might be right forLymphoma, Non-Hodgkin University Hospital, Limoges 40
Not applicableUnknownNCT01953770What this trial is testingChildhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008Who this might be right forChildhood Acute Lymphoblastic Leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology 3,000
Testing effectiveness (Phase 2)Study completedNCT00854425What this trial is testingL-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell LymphomaWho this might be right forLymphoma Fudan University 40
Testing effectiveness (Phase 2)WithdrawnNCT02538926What this trial is testingEtoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forB Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaRecurrent Adult Acute Lymphoblastic Leukemia+6 more University of Washington
Testing effectiveness (Phase 2)Study completedNCT03618238What this trial is testingAnlotinib for Advanced and Refractory Natural Killer /T-cell LymphomaWho this might be right forNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00136435What this trial is testingA Study in Adults With Untreated Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Dana-Farber Cancer Institute 100
Not applicableUnknownNCT01193933What this trial is testingMulticenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive TreatmentWho this might be right forPh-negative Adult Acute Lymphoblastic Leukemia National Research Center for Hematology, Russia 321
Testing effectiveness (Phase 2)UnknownNCT02229682What this trial is testingMild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX ChemotherapyWho this might be right forLymphoma,Non-Hodgkin Lymphoma,Extranodal NK/T-cell Lymphoma,Nasal-type, Sun Yat-sen University 40
Large-scale testing (Phase 3)Study completedNCT00784017What this trial is testingComparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic LeukaemiaWho this might be right forAcute Lymphoblastic Leukemia medac GmbH 199
Testing effectiveness (Phase 2)Study completedNCT03246750What this trial is testingB-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell LymphomaWho this might be right forExtranodal NK/T-cell Lymphoma The Thai Lymphoma Study Group 34